科美诊断:预计2025年净利润同比下降62.23%-68.52%

Core Viewpoint - The company, Komei Diagnostics, anticipates a significant decline in net profit for the year 2025, projecting a decrease of 62.23% to 68.52% compared to the previous year [1] Financial Projections - The expected net profit for 2025 is estimated to be between RMB 40 million and RMB 48 million [1] - The net profit attributable to the parent company, after deducting non-recurring gains and losses, is projected to be between RMB 26 million and RMB 32 million, reflecting a year-on-year decrease of 68.23% to 74.19% [1] - In 2024, the company reported a net profit of RMB 127 million, with the net profit attributable to the parent company, after deducting non-recurring gains and losses, amounting to RMB 101 million [1]

Chemclin Diagnostics-科美诊断:预计2025年净利润同比下降62.23%-68.52% - Reportify